Teladoc Health Inc. (NYSE:TDOC) shares traded 3.66% higher at $24.65 on Wall Street last session.
In accordance with the data, 29 analysts cover Teladoc Health Inc. (NYSE:TDOC). The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $40.00 and a low of $25.00, we find $29.00. Given the previous closing price of $23.78, this indicates a potential upside of 21.95 percent. TDOC stock price is now -3.32% away from the 50-day moving average and -11.47% away from the 200-day moving average. The market capitalization of the company currently stands at $4.09B.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
Sponsored
It has been rated a hold by 23 analysts and a buy by 6. Brokers who have rated the stock have averaged $30.18 as their price target over the next twelve months.
.
In other news, Trencher Daniel, CHIEF STRATEGY OFFICER sold 1,000 shares of the company’s stock on May 17. The stock was sold for $23,810 at an average price of $23.81. Upon completion of the transaction, the CHIEF STRATEGY OFFICER now directly owns 23,520 shares in the company, valued at $0.58 million. An SEC document containing details of the transaction can be found on the SEC’s website. On May 04, CHIEF INNOVATION OFFICER Jensen Claus Torp sold 1,699 shares of the business’s stock. A total of $43,566 was realized by selling the stock at an average price of $25.64. This leaves the insider owning 13,540 shares of the company worth $0.33 million. Insiders disposed of 121,232 shares of company stock worth roughly $2.99 million over the past 1 year. A total of 0.10% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in TDOC stock. A new stake in Teladoc Health Inc. shares was purchased by QUBE RESEARCH & TECHNOLOGIES LTD during the first quarter worth $14,031,000. QUANTBOT TECHNOLOGIES LP invested $6,035,000 in shares of TDOC during the first quarter. In the first quarter, ALGERT GLOBAL LLC acquired a new stake in Teladoc Health Inc. valued at approximately $3,496,000. LEFT BRAIN WEALTH MANAGEMENT, LLC acquired a new stake in TDOC for approximately $2,903,000. JUPITER ASSET MANAGEMENT LTD purchased a new stake in TDOC valued at around $2,215,000 in the second quarter. In total, there are 662 active investors with 83.80% ownership of the company’s stock.
Teladoc Health Inc. (NYSE: TDOC) opened at $23.80 on Monday. During the past 12 months, Teladoc Health Inc. has had a low of $21.60 and a high of $44.66. As of last week, the company has a debt-to-equity ratio of 0.68, a current ratio of 3.40, and a quick ratio of 3.30. The fifty day moving average price for TDOC is $25.52 and a two-hundred day moving average price translates $27.78 for the stock.
The latest earnings results from Teladoc Health Inc. (NYSE: TDOC) was released for Mar, 2023. According to the Health Information Services Company, earnings per share came in at -$0.42, beating analysts’ expectations of -$0.5 by 0.08. This compares to -$41.58 EPS in the same period last year. The company reported revenue of $629.24 million for the quarter, compared to $565.35 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 11.3 percent. For the current quarter, analysts expect TDOC to generate $649.39M in revenue.
